시장보고서
상품코드
1957406

의료기기 임상시험 시장 보고서(2026년)

Medical Device Clinical Trials Global Market Report 2026

발행일: | 리서치사: The Business Research Company | 페이지 정보: 영문 250 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

의료기기 임상시험 시장 규모는 최근 현저한 성장을 이루고 있습니다. 2025년 180억 7,000만 달러에서 2026년에는 193억 6,000만 달러로, CAGR 7.2%로 확대될 것으로 예상됩니다. 지난 수년간의 성장은 의료기기 혁신의 발전, 엄격한 규제 승인 요건, 환자 안전성 검증에 대한 수요 증가, 병원 기반 임상 연구 확대, 임상 증거 창출에 대한 투자 증가에 기인한 것으로 보입니다.

의료기기 임상시험 시장 규모는 향후 몇 년간 강력한 성장이 전망됩니다. 2030년에는 253억 5,000만 달러에 달하고, CAGR은 7.0%가 될 전망입니다. 예측 기간 동안 성장 요인으로는 웨어러블 및 커넥티드 의료기기의 보급, 기기 성능에 대한 규제 당국의 모니터링 강화, 디지털 임상시험 플랫폼의 확대, 임상시험에서 원격 환자 모니터링 도입 증가, 임상연구의 세계화 진전 등을 꼽을 수 있습니다. 예측 기간 동안 주요 동향으로는 분산형 임상시험의 도입 증가, 기기 시험에서 실제 데이터 활용 확대, 승인 후 및 장기 안전성 시험에 대한 관심 증가, 적응형 및 하이브리드 시험 설계의 확대, 규제 준수 시험 관리에 대한 수요 증가 등을 들 수 있습니다.

향후 몇 년 동안 만성질환의 유병률 증가가 의료기기 임상시험 시장의 성장을 견인할 것으로 예상됩니다. 만성질환은 장기간에 걸쳐 서서히 진행되어 지속적인 의료관리가 필요한 건강상태를 말합니다. 이러한 증가는 장시간 앉아있는 자세와 스크린 사용으로 인한 칼로리 소모 감소, 심혈관 기능 저하 등 앉아서 생활하는 생활습관과 관련이 있으며, 비만, 당뇨, 고혈압 등의 질병을 유발하는 요인으로 작용하고 있습니다. 만성질환의 부담이 증가함에 따라 효과적인 진단, 치료, 질병 관리를 위한 혁신적인 의료기기의 개발 및 검증을 위한 임상시험의 필요성이 높아지고 있습니다. 예를 들어, 2023년 6월 미국 공중보건 연구기관인 건강지표평가연구소(IHME)가 발표한 보고서에 따르면, 전 세계적으로 5억 명 이상이 당뇨병을 앓고 있으며, 이 숫자는 2050년까지 13억 명으로 두 배 이상 늘어날 것으로 예측됩니다. 이러한 만성질환의 유병률 증가가 의료기기 임상시험 시장 확대를 견인하고 있습니다.

의료기기 임상시험 시장의 주요 기업들은 임상시험 프로토콜 최적화, 자원 배분 효율화, 시험 효율성 향상과 비용 절감을 동시에 실현하기 위해 AI 기반 의료기기 소프트웨어 개발에 집중하고 있습니다. AI 탑재 의료기기 소프트웨어는 머신러닝과 딥러닝 알고리즘을 포함한 인공지능을 활용하여 의료 업무를 지원하거나 자동화를 실현합니다. 예를 들어, 2025년 1월 스위스에 본사를 둔 제약회사 리스크클릭(Risklick)은 의료기기 임상시험을 가속화하고 최적화하기 위해 설계된 AI 기반 소프트웨어인 'Protocol AI'를 발표했습니다. Protocol AI는 자연어 처리(NLP)와 머신러닝(ML)을 활용하여 임상 데이터, 학술 논문, 규제 문서를 분석하여 몇 분 만에 임상시험 프로토콜을 자동 생성합니다. 이 혁신적인 기술을 통해 기존 약 6개월이 소요되던 프로토콜 개발 시간과 비용을 대폭 절감할 수 있으며, 제약 분야에서는 문서 작성 시간을 최대 50%까지 단축할 수 있는 것으로 입증되었습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의가 공급망에 미치는 영향, 코로나가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장에서 세계의 총 잠재 시장 규모(TAM)

제9장 시장 세분화

제10장 지역별·국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자 환경

제36장 경쟁 구도와 기업 개요

제37장 기타 주요 기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 인수합병

제40장 시장 잠재력이 높은 국가, 부문, 전략

제41장 부록

KSM

Medical device clinical trials are research studies designed to evaluate the safety and effectiveness of medical devices in humans. The process includes phases such as feasibility, pivotal, and post-approval studies, which are necessary for regulatory approval. These trials generate critical data to support device market authorization and ongoing safety monitoring.

The main study types in medical device clinical trials include feasibility and pilot studies, pivotal studies, FDA premarket approval (PMA) applications, and post-approval studies. Feasibility and pilot studies are early-phase trials conducted with a small group of participants to assess the practicality, safety, and potential challenges of a new device before progressing to larger trials. These studies are conducted across various indications, including cardiovascular, neurology, orthopedic, diagnostic imaging, anesthesia and respiratory devices, and others. Study designs typically include interventional, observational, and expanded access approaches.

Tariffs have influenced the medical device clinical trials market by increasing costs for imported trial devices, monitoring equipment, and data collection technologies. These impacts are most evident in cardiovascular, orthopedic, and diagnostic device trials, particularly across North America, Europe, and Asia-Pacific regions. Higher tariffs have raised overall trial execution costs and delayed multinational study timelines. However, tariffs have also encouraged local trial execution, regional manufacturing of investigational devices, and increased domestic clinical research capacity.

The medical device clinical trials market research report is one of a series of new reports from The Business Research Company that provides medical device clinical trials market statistics, including medical device clinical trials industry global market size, regional shares, competitors with a medical device clinical trials market share, detailed medical device clinical trials market segments, market trends and opportunities, and any further data you may need to thrive in the medical device clinical trials industry. This medical device clinical trials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The medical device clinical trials market size has grown strongly in recent years. It will grow from $18.07 billion in 2025 to $19.36 billion in 2026 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to growth in medical device innovation, stringent regulatory approval requirements, rising demand for patient safety validation, expansion of hospital-based clinical research, increasing investment in clinical evidence generation.

The medical device clinical trials market size is expected to see strong growth in the next few years. It will grow to $25.35 billion in 2030 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to growth in wearable and connected medical devices, increasing regulatory scrutiny on device performance, expansion of digital trial platforms, rising adoption of remote patient monitoring in trials, increasing globalization of clinical studies. Major trends in the forecast period include increasing adoption of decentralized clinical trials, growing use of real-world evidence in device trials, rising focus on post-approval and long-term safety studies, expansion of adaptive and hybrid trial designs, increasing demand for regulatory-compliant trial management.

The increasing prevalence of chronic diseases is expected to drive the growth of the medical device clinical trials market in the coming years. Chronic diseases are long-term health conditions that progress gradually and require ongoing medical management. Their rise is linked to sedentary lifestyles, where extended periods of sitting or screen use reduce calorie expenditure and weaken cardiovascular health, contributing to conditions such as obesity, diabetes, and hypertension. The growing burden of chronic diseases fuels the need for medical device clinical trials to develop and validate innovative devices for effective diagnosis, treatment, and disease management. For example, in June 2023, the Institute for Health Metrics and Evaluation, a US-based public health research institute, reported that over half a billion people worldwide were living with diabetes, a number projected to more than double to 1.3 billion by 2050. Consequently, the rising prevalence of chronic diseases is driving the expansion of the medical device clinical trials market.

Major companies in the medical device clinical trials market are focusing on developing AI-powered medical device software to optimize clinical trial protocols, streamline resource allocation, and enhance trial efficiency while reducing costs. AI-powered medical device software uses artificial intelligence, including machine learning and deep learning algorithms, to support or automate healthcare tasks. For example, in January 2025, Risklick, a Switzerland-based pharmaceutical company, launched Protocol AI, an AI-based software designed to accelerate and optimize clinical trials for medical devices. Protocol AI employs Natural Language Processing (NLP) and Machine Learning (ML) to analyze clinical data, publications, and regulatory documents, automatically generating clinical trial protocols in minutes. This innovation significantly reduces the time and cost of protocol development, which traditionally takes around six months, and has demonstrated up to a 50% reduction in document preparation time for medicinal products.

In January 2024, eMed, a US-based health services company, acquired Science 37 for $38 million. The acquisition enhances eMed's clinical research capabilities by integrating telehealth and diagnostic services with decentralized trial technology, improving patient enrollment and expanding access to underrepresented populations. Science 37 is a US-based research company specializing in decentralized clinical trials, including those for medical devices.

Major companies operating in the medical device clinical trials market are Abbott Laboratories, Siemens Healthineers, Stryker Corporation, Philips Healthcare, Baxter International, Roche Diagnostics, ICON, Intuitive Surgical, Edwards Lifesciences, Fortrea, Medidata, NAMSA, Veranex, TFS HealthScience, Avania, Parexel, Meditrial, Syneos Health, Qserve CRO, Clinius Ltd, Eclevar Medtech, 1med Sa, ISS AG

North America was the largest region in the medical device clinical trials market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical device clinical trials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the medical device clinical trials market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The medical device clinical trials market includes revenues earned by entities by providing services such as clinical trial design and management, regulatory consulting, site selection and monitoring, patient recruitment, data management, and statistical analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The medical device clinical trials market also includes sales of diagnostic devices, therapeutic devices, surgical instruments, monitoring equipment, implantable devices, wearable health technologies, and medical imaging systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Medical Device Clinical Trials Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses medical device clinical trials market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for medical device clinical trials ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The medical device clinical trials market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Study Type: Feasibility And Pilot Study; Pivotal Study; FDA Premarket Approval (PMA) Application; Post-Approval Study
  • 2) By Indication: Cardiovascular Devices; Neurology Devices; Orthopedic Devices; Diagnostic Imaging; Anesthesia And Respiratory Devices; Other Indications
  • 3) By Study Design: Interventional; Observational; Expanded Access
  • Subsegments:
  • 1) By Feasibility And Pilot Study: First-in-Human (FIH) Trials; Device Safety Assessment; Procedural Feasibility Studies; Prototype Testing
  • 2) By Pivotal Study: Comparative Effectiveness Studies; Randomized Controlled Trials (RCTs); Non-Inferiority Trials; Superiority Trials
  • 3) By FDA PMA (Pre-Market Approval) Application: Clinical Data Submission; Device Risk Analysis; Effectiveness Evidence Studies
  • 4) By Post-Approval Study: Long-Term Safety Monitoring; Real-World Evidence Collection; Registry Studies; Comparative Outcome Studies
  • Companies Mentioned: Abbott Laboratories; Siemens Healthineers; Stryker Corporation; Philips Healthcare; Baxter International; Roche Diagnostics; ICON; Intuitive Surgical; Edwards Lifesciences; Fortrea; Medidata; NAMSA; Veranex; TFS HealthScience; Avania; Parexel; Meditrial; Syneos Health; Qserve CRO; Clinius Ltd; Eclevar Medtech; 1med Sa; ISS AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Medical Device Clinical Trials Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Medical Device Clinical Trials Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Medical Device Clinical Trials Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Medical Device Clinical Trials Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Artificial Intelligence & Autonomous Intelligence
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Industry 4.0 & Intelligent Manufacturing
    • 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
    • 4.1.5 Biotechnology, Genomics & Precision Medicine
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Decentralized Clinical Trials
    • 4.2.2 Growing Use Of Real-World Evidence In Device Trials
    • 4.2.3 Rising Focus On Post-Approval And Long-Term Safety Studies
    • 4.2.4 Expansion Of Adaptive And Hybrid Trial Designs
    • 4.2.5 Increasing Demand For Regulatory-Compliant Trial Management

5. Medical Device Clinical Trials Market Analysis Of End Use Industries

  • 5.1 Medical Device Manufacturers
  • 5.2 Contract Research Organizations
  • 5.3 Hospitals
  • 5.4 Academic Research Institutes
  • 5.5 Regulatory And Compliance Organizations

6. Medical Device Clinical Trials Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Medical Device Clinical Trials Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Medical Device Clinical Trials PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Medical Device Clinical Trials Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Medical Device Clinical Trials Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Medical Device Clinical Trials Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Medical Device Clinical Trials Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Medical Device Clinical Trials Market Segmentation

  • 9.1. Global Medical Device Clinical Trials Market, Segmentation By Study Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Feasibility And Pilot Study, Pivotal Study, FDA Premarket Approval (PMA) Application, Post-Approval Study
  • 9.2. Global Medical Device Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Cardiovascular Devices, Neurology Devices, Orthopedic Devices, Diagnostic Imaging, Anesthesia And Respiratory Devices, Other Indications
  • 9.3. Global Medical Device Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Interventional, Observational, Expanded Access
  • 9.4. Global Medical Device Clinical Trials Market, Sub-Segmentation Of Feasibility And Pilot Study, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • First-in-Human (FIH) Trials, Device Safety Assessment, Procedural Feasibility Studies, Prototype Testing
  • 9.5. Global Medical Device Clinical Trials Market, Sub-Segmentation Of Pivotal Study, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Comparative Effectiveness Studies, Randomized Controlled Trials (RCTs), Non-Inferiority Trials, Superiority Trials
  • 9.6. Global Medical Device Clinical Trials Market, Sub-Segmentation Of FDA PMA (Pre-Market Approval) Application, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Clinical Data Submission, Device Risk Analysis, Effectiveness Evidence Studies
  • 9.7. Global Medical Device Clinical Trials Market, Sub-Segmentation Of Post-Approval Study, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Long-Term Safety Monitoring, Real-World Evidence Collection, Registry Studies, Comparative Outcome Studies

10. Medical Device Clinical Trials Market Regional And Country Analysis

  • 10.1. Global Medical Device Clinical Trials Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Medical Device Clinical Trials Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Medical Device Clinical Trials Market

  • 11.1. Asia-Pacific Medical Device Clinical Trials Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Medical Device Clinical Trials Market, Segmentation By Study Type, Segmentation By Indication, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Medical Device Clinical Trials Market

  • 12.1. China Medical Device Clinical Trials Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Medical Device Clinical Trials Market, Segmentation By Study Type, Segmentation By Indication, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Medical Device Clinical Trials Market

  • 13.1. India Medical Device Clinical Trials Market, Segmentation By Study Type, Segmentation By Indication, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Medical Device Clinical Trials Market

  • 14.1. Japan Medical Device Clinical Trials Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Medical Device Clinical Trials Market, Segmentation By Study Type, Segmentation By Indication, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Medical Device Clinical Trials Market

  • 15.1. Australia Medical Device Clinical Trials Market, Segmentation By Study Type, Segmentation By Indication, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Medical Device Clinical Trials Market

  • 16.1. Indonesia Medical Device Clinical Trials Market, Segmentation By Study Type, Segmentation By Indication, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Medical Device Clinical Trials Market

  • 17.1. South Korea Medical Device Clinical Trials Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Medical Device Clinical Trials Market, Segmentation By Study Type, Segmentation By Indication, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Medical Device Clinical Trials Market

  • 18.1. Taiwan Medical Device Clinical Trials Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Medical Device Clinical Trials Market, Segmentation By Study Type, Segmentation By Indication, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Medical Device Clinical Trials Market

  • 19.1. South East Asia Medical Device Clinical Trials Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Medical Device Clinical Trials Market, Segmentation By Study Type, Segmentation By Indication, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Medical Device Clinical Trials Market

  • 20.1. Western Europe Medical Device Clinical Trials Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Medical Device Clinical Trials Market, Segmentation By Study Type, Segmentation By Indication, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Medical Device Clinical Trials Market

  • 21.1. UK Medical Device Clinical Trials Market, Segmentation By Study Type, Segmentation By Indication, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Medical Device Clinical Trials Market

  • 22.1. Germany Medical Device Clinical Trials Market, Segmentation By Study Type, Segmentation By Indication, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Medical Device Clinical Trials Market

  • 23.1. France Medical Device Clinical Trials Market, Segmentation By Study Type, Segmentation By Indication, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Medical Device Clinical Trials Market

  • 24.1. Italy Medical Device Clinical Trials Market, Segmentation By Study Type, Segmentation By Indication, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Medical Device Clinical Trials Market

  • 25.1. Spain Medical Device Clinical Trials Market, Segmentation By Study Type, Segmentation By Indication, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Medical Device Clinical Trials Market

  • 26.1. Eastern Europe Medical Device Clinical Trials Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Medical Device Clinical Trials Market, Segmentation By Study Type, Segmentation By Indication, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Medical Device Clinical Trials Market

  • 27.1. Russia Medical Device Clinical Trials Market, Segmentation By Study Type, Segmentation By Indication, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Medical Device Clinical Trials Market

  • 28.1. North America Medical Device Clinical Trials Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Medical Device Clinical Trials Market, Segmentation By Study Type, Segmentation By Indication, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Medical Device Clinical Trials Market

  • 29.1. USA Medical Device Clinical Trials Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Medical Device Clinical Trials Market, Segmentation By Study Type, Segmentation By Indication, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Medical Device Clinical Trials Market

  • 30.1. Canada Medical Device Clinical Trials Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Medical Device Clinical Trials Market, Segmentation By Study Type, Segmentation By Indication, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Medical Device Clinical Trials Market

  • 31.1. South America Medical Device Clinical Trials Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Medical Device Clinical Trials Market, Segmentation By Study Type, Segmentation By Indication, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Medical Device Clinical Trials Market

  • 32.1. Brazil Medical Device Clinical Trials Market, Segmentation By Study Type, Segmentation By Indication, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Medical Device Clinical Trials Market

  • 33.1. Middle East Medical Device Clinical Trials Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Medical Device Clinical Trials Market, Segmentation By Study Type, Segmentation By Indication, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Medical Device Clinical Trials Market

  • 34.1. Africa Medical Device Clinical Trials Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Medical Device Clinical Trials Market, Segmentation By Study Type, Segmentation By Indication, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Medical Device Clinical Trials Market Regulatory and Investment Landscape

36. Medical Device Clinical Trials Market Competitive Landscape And Company Profiles

  • 36.1. Medical Device Clinical Trials Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Medical Device Clinical Trials Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Medical Device Clinical Trials Market Company Profiles
    • 36.3.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Philips Healthcare Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Baxter International Overview, Products and Services, Strategy and Financial Analysis

37. Medical Device Clinical Trials Market Other Major And Innovative Companies

  • Roche Diagnostics, ICON, Intuitive Surgical, Edwards Lifesciences, Fortrea, Medidata, NAMSA, Veranex, TFS HealthScience, Avania, Parexel, Meditrial, Syneos Health, Qserve CRO, Clinius Ltd

38. Global Medical Device Clinical Trials Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Medical Device Clinical Trials Market

40. Medical Device Clinical Trials Market High Potential Countries, Segments and Strategies

  • 40.1 Medical Device Clinical Trials Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Medical Device Clinical Trials Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Medical Device Clinical Trials Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제